Pharma companies had to work through the lockdown as essential services. What were some challenges related to staffing, accommodation, training younger staff to perform without seniors who might have been in the higher age risk group, permits, etc.?
Pharma companies have both blue-collar and white-collar employees. They typically operate across different models and are involved in manufacturing, R&D, field sales and more.
In the last few months, many companies were operational around the clock to meet the demand for products. The industry, as a whole, had to adapt to newer ways of working in a very short period. There were various challenges with the supply chain, procurement, retaining quality and meeting production deadlines.
One of the biggest challenges has been staffing. All sectors have seen their share of attrition in the past few months, which has created challenges for training and maintaining quality and continuity of operations.
In pharma and other sectors, a solution to this has been adopting contract staffing and managed services. These services allow companies to expand their workforce without undertaking the pain of training and managing the staff.
In the current situation, while the industry needs to add people, constant disruptions are a challenge to training. Many companies have been addressing this issue by virtual training programmes for their employees.
With these challenges in place, upskilling and rapid learning applications will lead the way in future, which will help companies train their staff virtually.
A lot of pharma companies who worked through the lockdown had a sizeable section of staff getting the COVID-19 infection. How are they coping with staffing challenges, especially as the second wave looks to be worse than the first?
この記事は Express Pharma の June 2021 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は Express Pharma の June 2021 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
Powerful Process Control with IND500x Weighing Indicators
Ensuring consistent quality in hazardous environments, particularly in Ex-Areas (Zone 1/21, Division 1), is a critical aspect of industrial operations. The IND500x weighing indicators from METTLER TOLEDO provide a robust solution for these challenging settings, offering optimized safety and productivity.
Ensuring clean room integrity with prime clean reset high-speed doors
Prime Clean Reset high-speed doors ensure airtight seals, minimising air permeability and contamination in clean rooms. Designed for sensitive environments, they enhance operational efficiency and meet rigorous regulatory standards, making them ideal for pharmaceutical and biotech industries
Complete environmental monitoring solution - testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
Adaptive Manufacturing:-The new flexibility in medical device assembly
Unlike traditional, rigid production lines, B&R's adaptive machines seamlessly adjust to the requirements of each device, dynamically adapting to each unique process
Reshaping pharma safety with active packaging innovations
CILICANT is revolutionising active packaging with solutions tailored for the most sensitive formulations. Meet the innovators driving stability, safety, and impurity control in pharma packaging at CPhI India
UNLOCKING GROWTH FRONTIERS
Vadodara Pharma Summit 2024 brought together industry leaders and experts to highlight the city's pivotal role in India's pharma landscape and explore collaborative strategies to strengthen India's pharma innovation ecosystem
Optimising cloud provisioning for pharmaceutical compliance and operational excellence
Suresh Perikala, Senior Engineering Lead - DevOps and Cloud Engineering Practice, Altimetrik
Accelerating pharma's sustainability efforts
Avinaw Prasad, Director, Climate Change & Sustainability, Deloitte India explains why integrating sustainability into the core pharma business strategy is essential for long-term success, analyses key focus areas and policy pushes which can incentivise companies to further evolve on the sustainability path
Drug Repurposing: Unlocking access to rare solutions
Drug repurposing, a quick, cost-effective path to deliver existing treatments to patients, can serve to expedite and expand healthcare access for patients with rare diseases
Optimising spend, maximising growth
Express Pharma, in partnership with IPA and CHEMEXCIL, powered by SAP, recently organised a thought leadership conclave on 'Reimagining spend management and supply chain' where cross functional experts explored strategies to drive value through supply chain transformation